For citations:
Lobzin Yu.V., Zhdanov K.V., Simbirtsev A.S., Yakovlev A.A., Kizhlo S.N., Fazilov V.H., Zharov S.N., Lebedev M.F. Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin. Journal Infectology. 2012;4(4):80-89. (In Russ.) https://doi.org/10.22625/2072-6732-2012-4-4-80-89
.png)
.png)
Email this article 